Blau Farmaceutica (BSP:BLAU3) Research & Development : R$31 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Blau Farmaceutica's Research & Development for the three months ended in Mar. 2025 was R$7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was R$31 Mil.

Blau Farmaceutica Research & Development Historical Data

The historical data trend for Blau Farmaceutica's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica Research & Development Chart

Blau Farmaceutica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

28.54

38.91

42.40

30.25

Blau Farmaceutica Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Research & Development	Get a 7-Day Free Trial															5.54	7.61	8.45	8.66	6.64

Blau Farmaceutica Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$31 Mil.

Blau Farmaceutica (BSP:BLAU3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Blau Farmaceutica Research & Development Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Blau Farmaceutica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » Research & Development

Traded in Other Exchanges

N/A

Address

Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030

Website

https://www.blau.com

Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica Headlines

No Headlines